These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 32405783)
1. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Katulanda P; Dissanayake HA; Ranathunga I; Ratnasamy V; Wijewickrama PSA; Yogendranathan N; Gamage KKK; de Silva NL; Sumanatilleke M; Somasundaram NP; Matthews DR Diabetologia; 2020 Aug; 63(8):1440-1452. PubMed ID: 32405783 [TBL] [Abstract][Full Text] [Related]
2. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review. Wicaksana AL; Hertanti NS; Ferdiana A; Pramono RB Diabetes Metab Syndr; 2020; 14(5):1109-1120. PubMed ID: 32659694 [TBL] [Abstract][Full Text] [Related]
3. Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic. Sacks LJ; Pham CT; Fleming N; Neoh SL; Ekinci EI Diabetes Res Clin Pract; 2020 Aug; 166():108296. PubMed ID: 32623041 [TBL] [Abstract][Full Text] [Related]
4. Glucovigilance in COVID-19. Lamptey R; Ahomagnon S; Acheampong F; Kalra S J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386 [TBL] [Abstract][Full Text] [Related]
5. Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion Statement. Malek M; Hosseinpanah F; Aghaei Meybodi HR; Jahed SA; Hadaegh F; Sharghi S; Esteghamati A; Khamseh ME Arch Iran Med; 2020 Aug; 23(8):564-567. PubMed ID: 32894970 [TBL] [Abstract][Full Text] [Related]
6. Social isolation during Covid-19: Boon or bane to diabetes management. Gupta S; Tang C; Higgs P Diabetes Metab Syndr; 2020; 14(4):567-568. PubMed ID: 32413820 [No Abstract] [Full Text] [Related]
7. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China. Zhou J; Tan J Metabolism; 2020 Jun; 107():154216. PubMed ID: 32220612 [No Abstract] [Full Text] [Related]
8. Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic. Ghosh A; Dutta K; Tyagi K; Gupta R; Misra A Diabetes Metab Syndr; 2020; 14(4):577-578. PubMed ID: 32416526 [No Abstract] [Full Text] [Related]
9. The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy. Preskorn SH J Psychiatr Pract; 2020 May; 26(3):219-227. PubMed ID: 32421292 [TBL] [Abstract][Full Text] [Related]
10. Diabetes and COVID-19: Global and regional perspectives. Jeong IK; Yoon KH; Lee MK Diabetes Res Clin Pract; 2020 Aug; 166():108303. PubMed ID: 32623038 [TBL] [Abstract][Full Text] [Related]
11. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Gupta R; Ghosh A; Singh AK; Misra A Diabetes Metab Syndr; 2020; 14(3):211-212. PubMed ID: 32172175 [No Abstract] [Full Text] [Related]
12. Commentary: COVID-19 in patients with diabetes. Hill MA; Mantzoros C; Sowers JR Metabolism; 2020 Jun; 107():154217. PubMed ID: 32220611 [No Abstract] [Full Text] [Related]
13. The Time of Uncertainty in Poland. Dzida GJ J Diabetes Sci Technol; 2020 Jul; 14(4):731-732. PubMed ID: 32460551 [No Abstract] [Full Text] [Related]
14. Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic. Pasquel FJ; Umpierrez GE J Diabetes Sci Technol; 2020 Jul; 14(4):705-707. PubMed ID: 32370606 [TBL] [Abstract][Full Text] [Related]
16. The Coronavirus 2019 Pandemic and Diabetes: An International Perspective. Klonoff DC J Diabetes Sci Technol; 2020 Jul; 14(4):703-704. PubMed ID: 32517506 [No Abstract] [Full Text] [Related]
17. Relative Limited Impact of COVID-19 on Diabetes: A Personal View. de Galan BE J Diabetes Sci Technol; 2020 Jul; 14(4):727-728. PubMed ID: 32468834 [No Abstract] [Full Text] [Related]
18. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668 [TBL] [Abstract][Full Text] [Related]
19. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494 [TBL] [Abstract][Full Text] [Related]
20. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan. Zhang Y; Li H; Zhang J; Cao Y; Zhao X; Yu N; Gao Y; Ma J; Zhang H; Zhang J; Guo X; Liu X Diabetes Obes Metab; 2020 Aug; 22(8):1443-1454. PubMed ID: 32406594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]